The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCIP.L Regulatory News (CIP)

  • There is currently no data for CIP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

3 May 2022 16:28

RNS Number : 1683K
CIP Merchant Capital Ltd
03 May 2022
 

3 May 2022

 

CIP MERCHANT CAPITAL LIMITED

("CIP Merchant Capital" or the "Company")

 

Holding in Company

 

CIP Merchant Capital (AIM:CIP), a closed-ended investment company, announces that Goldfinch SA ("Goldfinch"), a company wholly owned in equal proportion by Marco Fumagalli and Carlo Sgarbi, has sold 4,836,527 ordinary shares of 1p each in the capital of the Company ("Ordinary Shares") and Carlo Sgarbi has sold an additional 200,000 Ordinary Shares at a price of 60 pence per Ordinary Share (together, the "Share Sales") pursuant to the acceptance of the offer made by Corporation Financière Européenne S.A.. Following the Share Sales, Goldfinch, Marco Fumagalli and Carlo Sgarbi hold no Ordinary Shares.

 

 

For further information, please contact:

 

Merchant Capital Manager Limited (Investment Manager)

Wikus Van Schalkwyk

 

+44 1481 749 363

Strand Hanson Limited (Financial & Nominated Adviser and Broker)

Stuart Faulkner / Matthew Chandler / James Bellman / Rob Patrick

+44 20 7409 3494

 

 

The information contained in this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulation (EU) No. 596/2014 (which applies in the United Kingdom by operation of the European Union (Withdrawal) Act 2018 (as amended)). The person responsible for arranging release of this announcement on behalf of CIP is Adrian Collins.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
HOLUOUVRUSUVRAR
Date   Source Headline
20th Feb 201811:17 amRNSKey Information Document
20th Feb 20187:00 amRNSNet Asset Value(s)
13th Feb 201810:13 amRNSDirector Declaration
13th Feb 20187:00 amRNSNet Asset Value(s)
6th Feb 20187:00 amRNSNet Asset Value(s)
30th Jan 20187:00 amRNSNet Asset Value(s)
23rd Jan 20187:00 amRNSNet Asset Value(s)
22nd Jan 20185:00 pmRNSAcquisition
16th Jan 20187:00 amRNSNet Asset Value(s)
22nd Dec 20177:00 amRNSOrdinary Share Subscription & Admission to Trading

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.